Skip Ribbon Commands
Skip to main content

Terumo Pharmaceutical Solutions wins Asia-Pacific Industry Award

25/09/2020 - TOKYO, JAPAN

Tokyo-based Terumo Corporation (TSE: 4543) has today announced  that Terumo Pharmaceutical Solutions  has been awarded the Asia-Pacific Bioprocessing Excellence Award 2020 on July 7th at the Asia- Pacific Bio processing Excellence awards 2020.

It was the third year in a row for Terumo Pharmaceutical Solutions to win the award. The event for the year was held virtually owing to COVID-19.

Terumo Pharmaceutical Solutions was nominated in the category, 'Best Bioprocessing Supplier Award: "Prefillable Syringes" and competed with several other established companies in the industry.

Ashit Sikka, Business Director, Terumo Pharmaceutical Solutions, India accepted this award on behalf of Terumo.

 "We are very excited about the interest our PLAJEX™ platform continues to receive on the market and look forward to supporting our customer's future requirements", commented Marco Chiadò Piat, President, Terumo Pharmaceutical Solutions.

The Asia-Pacific Bioprocessing Excellence Award organized by IMAPAC, seeks to give recognition to exceptional biopr ocessing experts, organizations and technologies that facilitate biomanufacturing excellence at enhanced speed, r educed cost and superior quality. Featuring top bioprocessing and biomanufacturing leaders in the industry, along with the latest advances in technologies and best practices in manufacturing, the Asia-Pacific Bioprocessing Excellence Awards applaud extraordinary leaders & trend-setters of today, and inspire innovators of tomorrow.

An esteemed panel of expert judges and the Biologics Manufacturing Asia committee shortlisted the nominees that have proven to be outstanding in their respective categories. They include key opinion leaders with more than 20 years of experience, Process Development Vice Presidents and Directors, Heads of Manufacturing and bioprocessing from all the key players in both Asia and on a global level.


About Terumo Pharmaceutical Solutions

Terumo Pharmaceutical Solutions has been crafting drug delivery devices for generations. Our unique skillset is based on the utmost care – for our industry, our customers and the patients whose quality of life depends on the highest level of healthcare.

Our business relationships are founded on precision, a strong work ethic and open dialogue. We pride ourselves on understanding your needs, anticipating new trends and maintaining constant dialogue with the pharmaceutical industry.

With almost 100 years of experience, we offer a full portfolio of scientific expertise and industry know-how. Our skills range from product design and development to logistics, regulatory affairs, clinical affairs and numerous business processes. Above all, we listen!

Just like our products, our partnerships are Carefully Crafted to benefit everyone.


About Terumo Corporation

Terumo (TSE:4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for nearly 100 years. Based in Tokyo and operating globally, Terumo employs more than 25,000 associates worldwide, to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer and has been bolstering healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice. Terumo will further strive to be of value to patients, medical professionals, and society at large.